Company Filing History:
Years Active: 2021
Title: Dana Kelly Vanatta: Innovator in Nucleic Acid Amplification
Introduction
Dana Kelly Vanatta is a notable inventor based in San Mateo, CA. She has made significant contributions to the field of molecular biology, particularly in the area of nucleic acid amplification testing. Her work focuses on the development of primers and probes that enhance the detection of specific nucleic acids in test samples.
Latest Patents
Dana Kelly Vanatta holds 1 patent related to her innovative work. The patent, titled "Polynucleotides for the amplification and detection of," discloses primers and probes designed for the detection of nucleic acids via nucleic acid amplification testing (NAAT). This technology is particularly useful for amplifying and determining the presence of nucleic acids, specifically targeting the Cytochrome C or ccpA gene for detection through loop-mediated isothermal amplification (LAMP) and molecular beacon hybridization.
Career Highlights
Dana is currently employed at Talis Biomedical Corporation, where she continues to advance her research and development efforts. Her expertise in molecular biology and her innovative approach to nucleic acid detection have positioned her as a valuable asset in her field.
Collaborations
Dana collaborates with talented professionals such as Andrea Dedent and Hedia Maamar, who contribute to her projects and research initiatives. Their combined efforts enhance the potential for groundbreaking advancements in nucleic acid amplification technologies.
Conclusion
Dana Kelly Vanatta's contributions to the field of molecular biology through her innovative patent and collaborative efforts highlight her role as a leading inventor in nucleic acid amplification. Her work continues to pave the way for advancements in diagnostic testing and molecular detection methods.